SAS Institute and etrials Worldwide will jointly provide an integrated platform for pharmaceutical and biotechnology companies to capture, manage, analyse and explore clinical trial research and operational data. This offering will combine etrials electronic data capture (EDC), electronic patient diary (EPD) and interactive voice response (IVR) software for entering data from clinical trials with SAS clinical trials data integration and analysis solution.
On SASs announcement note, it is said that this integrated platform, gives pharmaceutical, biotechnology and medical device companies the possibility to take advantage of industry-leading software on either a per-trial or a multiyear subscription basis, and therefore complete trials more cost effectively without making substantial investments in computer hardware, software, consulting and maintenance.
This joint offering is already available for North American customers through an ASP platform.
Notícias – Press-Releases